Screener
Bioventus BVS Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Bioventus in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.
The source filing: Bioventus’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:43 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001665988-26-000042
| Line item | June 27, 2026 | December 31, 2025 |
|---|---|---|
| Current portion of long-term debt | 18,750 | 15,000 |
| Other current liabilities | 4,144 | 4,210 |
| Total current liabilities | 152,451 | 160,380 |
| Long-term debt, less current portion | 229,702 | 278,951 |
| Deferred income tax liabilities | 568 | 433 |
| Other long-term liabilities | 13,213 | 15,348 |
| Total liabilities | 395,934 | 455,112 |
| Commitments and contingencies (Note 11) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bioventus's long-term debt?
- Bioventus (BVS) reported long-term debt of $229.7M in Q2 2026.
- How has Bioventus's long-term debt changed year-over-year?
- Bioventus's long-term debt decreased by 22.9% year-over-year, from $297.88M to $229.7M.
- What is the long-term trend for Bioventus's long-term debt?
- Over 5 years (2020 to 2025), Bioventus's long-term debt has grown at a 10.0% compound annual growth rate (CAGR), from $173.38M to $278.95M.
- What does long-term debt mean?
- Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.
Ask your AI about Bioventus's long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude